Addus HomeCare (NASDAQ:ADUS) EVP Michael Wattenbarger Sells 7,141 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Michael Wattenbarger sold 7,141 shares of the firm’s stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $124.67, for a total transaction of $890,268.47. Following the completion of the sale, the executive vice president directly owned 7,303 shares of the company’s stock, valued at approximately $910,465.01. This represents a 49.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Addus HomeCare Trading Up 3.2%

Shares of ADUS opened at $126.29 on Wednesday. The firm’s 50-day moving average price is $117.97 and its 200-day moving average price is $107.02. The firm has a market capitalization of $2.35 billion, a price-to-earnings ratio of 21.05, a PEG ratio of 1.62 and a beta of 0.75. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The company had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. During the same period in the prior year, the firm earned $1.56 earnings per share. Addus HomeCare’s revenue was up 7.0% on a year-over-year basis. Sell-side analysts anticipate that Addus HomeCare Corporation will post 6.36 EPS for the current year.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Hantz Financial Services Inc. increased its stake in shares of Addus HomeCare by 21.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after acquiring an additional 109 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Addus HomeCare by 16.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after acquiring an additional 111 shares during the period. Assenagon Asset Management S.A. lifted its position in Addus HomeCare by 2.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock valued at $593,000 after acquiring an additional 114 shares during the period. Net Worth Advisory Group lifted its position in Addus HomeCare by 4.1% during the 3rd quarter. Net Worth Advisory Group now owns 3,419 shares of the company’s stock valued at $382,000 after acquiring an additional 136 shares during the period. Finally, Hohimer Wealth Management LLC lifted its position in Addus HomeCare by 5.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,809 shares of the company’s stock valued at $311,000 after acquiring an additional 143 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Neutral Sentiment: Addus said it will participate in the 2026 Stephens Annual Investment Conference. The announcement provides an opportunity to meet investors but gives no new financial or operating guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
• Neutral Sentiment: A report listed short interest at zero shares, indicating no reported short position; however, its description of a “large increase” conflicts with that figure.
• Negative Sentiment: Several executives disclosed stock sales. CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his holding by 35.08%. Five EVPs collectively sold 32,697 shares for roughly $4.1 million. Insider sales can weigh on sentiment, although they do not by themselves establish a negative outlook. CEO sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing

Wall Street Analysts Forecast Growth

ADUS has been the topic of a number of research analyst reports. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Saturday. Barclays increased their target price on Addus HomeCare from $96.00 to $101.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 4th. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. UBS Group raised their target price on Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Finally, Raymond James Financial set a $137.00 price target on Addus HomeCare in a research report on Monday, September 28th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.